New Biologics and Targeted Therapies in Systemic Lupus: From New Molecular Targets to New Indications. A Systematic Review
Joint Bone Spine. 2023.
Despite advancements in the treatment of SLE, unmet needs are still high. A greater understanding of the pathogenesis of the disease has paved the way for an array of investigational drugs aimed at a wide range of key immune players. In this systematic review, Felten, et al. provide an updated view of targeted therapies currently licensed or in clinical development in SLE, with a focus on the most promising.
